ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SN. Smith & Nephew Plc

985.40
2.00 (0.20%)
Last Updated: 11:34:16
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Smith & Nephew Plc LSE:SN. London Ordinary Share GB0009223206 ORD USD0.20
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.00 0.20% 985.40 985.00 985.40 987.40 974.00 982.60 411,567 11:34:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Ortho,prosth,surg Appl,suply 5.55B 263M 0.3011 32.75 8.61B
Smith & Nephew Plc is listed in the Ortho,prosth,surg Appl,suply sector of the London Stock Exchange with ticker SN.. The last closing price for Smith & Nephew was 983.40p. Over the last year, Smith & Nephew shares have traded in a share price range of 887.00p to 1,316.00p.

Smith & Nephew currently has 873,398,889 shares in issue. The market capitalisation of Smith & Nephew is £8.61 billion. Smith & Nephew has a price to earnings ratio (PE ratio) of 32.75.

Smith & Nephew Share Discussion Threads

Showing 1026 to 1050 of 1325 messages
Chat Pages: 53  52  51  50  49  48  47  46  45  44  43  42  Older
DateSubjectAuthorDiscuss
14/9/2021
11:52
OK Covid protective measures winding down but infections up though looking as though starting to go down but deaths starting to increase -However with restrictions coming off and winter coming very likley (imo)to be an acceration to the upside of both cases hospitalisations and deaths and therefore a decline in elective surgery BAD for SN.


Use above link if you wish to double check trends -

pugugly
14/9/2021
10:28
A little good news here would be more than welcome given the positive interims. Surely the Company has a fair indication of upswing now as Covid measures wind down. I think it would be prudent to issue an interim t/u in view of the continued share price erosion if only to stop the rot.
luzley
10/9/2021
11:26
I'll take £18 now please.
Suet

suetballs
10/9/2021
11:02
BARCLAYS CUTS SMITH & NEPHEW PRICE TARGET TO 1,800 (1,825) PENCE - 'OVERWEIGHT'
philanderer
24/8/2021
19:32
SP has bounced several times from the approx 13.75 type area.
Some type of support around there?, not holding atm.

essentialinvestor
24/8/2021
18:58
Today's RNS details shares issued partly in lieu of annual fees.


If you read yesterday's RNS, it's yet another director sale.

essentialinvestor
24/8/2021
18:47
What's going on with this share director buys big price goes down.
csalvage
16/8/2021
09:24
I expect we will get increasingly positive updates going forward as pent-up demand escalates and facilities reopen to clear backlogs. American healthcare consumers are not the most patient in the world.
luzley
16/8/2021
09:23
Affluent areas of US are facing much better - that's where most joint surgery is focused.
luzley
16/8/2021
08:25
Ok so no quick profits - but long term I am optimistic.
Suet

suetballs
16/8/2021
08:16
Thing is most of their business is in the us where things are getting worse
spoole5
13/8/2021
22:19
Looking to invest here, this seems like a great company with bags of potential for a Covid recovery play. Watching closely.
chard1980
12/8/2021
14:49
H2 guidance is predicated on normalisation of the COVID pandemic in their
major markets. Now currently we have the COVID situation in the US rapidly deteriorating-
hopefully that may peak within the next few weeks.


May be that is discounted at the current share price level, or someone else will see longer
term value and make an offer for the Company.


Ian, interesting re the epidural, these days they are far more cautious using GA.
Back in the day you were often put under general for even minor surgery.

essentialinvestor
12/8/2021
14:39
Keyno, you’re right.
I got fed up waiting for someone to
make some enlightened comment that would put some life into this board, hopefully I’ve done that.
Now make some comment on what I said about
+37% to +49% that’s constructive !

basildublin
12/8/2021
13:23
Basil has only been on ADVFN since yesterday.
keyno
12/8/2021
11:49
Bought a few today. Gotta b cheap.
its the oxman
12/8/2021
10:49
Ian, when S&N say the numbers are the
correct interpretation of the guidance
it gives a certain validity to the figures.

basildublin
12/8/2021
10:49
Ian, when S&N say the numbers are the
correct interpretation of the guidance
it gives a certain validity to the figures.

basildublin
12/8/2021
10:18
Thank you, nothing wrong with doing your own research particularly when you can justify the end result to your own satisfaction.
ianood
12/8/2021
08:32
Ian I am a CA
I took the information supplied with H2
Accounts, asked questions of S&N, got prompt replies, finished up with Trading Profits
between +37% and +49% over 2020 to which they agreed. Simple !
DYOR

basildublin
11/8/2021
23:33
Basil, thank you. Please what research does that pertain to?
ianood
11/8/2021
20:26
Hold on to your S&N shares.
2021 trading profits are projected to rise between 37% and 49%over 2020 !

basildublin
10/8/2021
22:36
EI, for what it's worth both ops, 3 years apart, were done under an epidural.

I do hold S&N, however, I suspect it may not be for too much longer!

ianood
10/8/2021
17:28
Ian, good to hear of that positive personal experience,
surgery under GA is not an option for me so mine better hold out!.

The posts not intended to deter anyone from buying here,
just for discussion purposes only. Always dyor etc.


Phil, lovely price.

essentialinvestor
10/8/2021
17:10
EI, Interesting comment, I have 2 Stryker knees installed via their robotic arm system which guarantees precision of 1mm in limb length and <1 degree deviation in the rotation of the knee from the norm. I did think that SN would be a good base from which Stryker could scale up in UK/Europe but now having seen and felt the product results I am thinking why would they bother, it will gravitate to them by results alone! Also the Stryker system makes component parts comparatively easy to replace and therefore not a complete TKR in the extremely rare event of a failure!
ianood
Chat Pages: 53  52  51  50  49  48  47  46  45  44  43  42  Older

Your Recent History

Delayed Upgrade Clock